Pembrolizumab vs Warfarin
Pembrolizumab vs Warfarin: Overview
This comparison examines the pharmacological differences between Pembrolizumab and Warfarin.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Warfarin: Inhibits vitamin K epoxide reductase complex.
Pharmacokinetics
Half-life: Pembrolizumab — 26 days; Warfarin — 20-60 hours.
Chemical Properties
Molecular Formula: Warfarin — C19H16O4.
Molecular Weight: Warfarin — 308.3280 g/mol.
Type: Pembrolizumab — Antibody; Warfarin — Small molecule.